SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-26-019076 from Ambiq Micro, Inc. (AMBQ)

Ambiq Micro, Inc.
Date: Jan. 22, 2026 · CIK: 0001500412 · Accession: 0001193125-26-019076

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-292843

Date
January 22, 2026
Author
Title: Director
Form
CORRESP
Company
Ambiq Micro, Inc.

Letter

Re:

BofA Securities, Inc. One Bryant Park New York, New York 10036 UBS Securities LLC 11 Madison Avenue New York, New York 10010 January 22, 2026 VIA EDGAR U.S. Securities and Exchange Commission Office of Manufacturing Division of Corporation Finance Office of Finance 100 F Street, N.E. Washington, D.C. 20549

Attn:

Kristin Baldwin

Ambiq Micro, Inc.

Registration Statement on Form S-1 (File No. 333-292843)

Request for Acceleration of Effective Date

Requested Date:

January 22, 2026

Requested Time:

4:00 p.m., Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), we, as representatives of the several underwriters, hereby join in the request of Ambiq Micro, Inc. (the “ Company ”) for acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-292843) so that it becomes effective as of 4:00 p.m., Eastern time on January 22, 2026, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Cooley LLP, request by telephone that such Registration Statement be declared effective. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, in connection with the proposed offering.

Very truly yours,
BofA Securities, Inc. UBS Securities LLC
As representatives of the several
Underwriters listed in Schedule I of the Underwriting Agreement
By:

Show Raw Text
CORRESP
 1
 filename1.htm

 CORRESP

 BofA Securities, Inc.
 One Bryant Park New York, New York 10036
 UBS Securities LLC 11 Madison Avenue
 New York, New York 10010 January 22, 2026
 VIA EDGAR U.S. Securities and Exchange
Commission Office of Manufacturing Division of Corporation
Finance Office of Finance 100 F Street, N.E.
 Washington, D.C. 20549

 Attn:

 Kristin Baldwin

 Re:

 Ambiq Micro, Inc.

 Registration Statement on Form S-1 (File No. 333-292843)

 Request for Acceleration of Effective Date

 Requested Date:

 January 22, 2026

 Requested Time:

 4:00 p.m., Eastern Time
 Ladies and Gentlemen:
 In accordance with Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), we, as representatives of the several
underwriters, hereby join in the request of Ambiq Micro, Inc. (the “ Company ”) for acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File
No. 333-292843) so that it becomes effective as of 4:00 p.m., Eastern time on January 22, 2026, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Cooley LLP, request by telephone that such
Registration Statement be declared effective. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters,
wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be
reasonable to secure adequate distribution of the preliminary prospectus. We, the undersigned, as representatives of the several
underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities
Exchange Act of 1934, as amended, in connection with the proposed offering.

 Very truly yours,
 BofA Securities, Inc. UBS Securities LLC
 As representatives of the several
 Underwriters listed in Schedule I of the Underwriting Agreement

 By:

 BofA Securities, Inc.

 By:

 /s/ Michael Liloia

 Name: Michael Liloia

 Title: Director

 By:

 UBS Securities LLC

 By:

 /s/ Austin Gobbo

 Name: Austin Gobbo

 Title: Director

 By:

 /s/ James Rainey

 Name: James Rainey

 Title: Associate Director

 cc:
 Fumihide Esaka, Ambiq Micro, Inc.
 Scott Hanson, Ph.D., Ambiq Micro, Inc.
 Jeff Winzeler, Ambiq Micro, Inc.
 Christina T. Roupas, Cooley LLP
 Courtney M.W. Tygesson, Cooley LLP
 Michael Platt, Cooley LLP Alan
F. Denenberg, Davis Polk & Wardwell LLP Emily Roberts, Davis Polk & Wardwell LLP
 [ Signature Page to Underwriters’ Acceleration Request ]